Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00508209 | Bortezomib and High-dose Melphalan at Myeloma Relapse | unknown | Phase 2 | 50 | Nordic Myeloma Study GroupOTHER | 3 | Jun 22, 2010 | clinicaltrials |
| NCT01148173 | High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas | unknown | Phase 2 | 30 | Charite University, Berlin, GermanyOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT00072488 | Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma | unknown | N/A | 226 | American College of Radiology Imaging NetworkNETWORK | 2 | Jun 8, 2010 | clinicaltrials |
| NCT00868478 | The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) | unknown | Phase 1 / Phase 2 | 15 | Kaplan Medical CenterOTHER | 1 | Jun 2, 2010 | clinicaltrials |
| NCT01132989 | Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma(REvMM2009) | unknown | Phase 2 | 10 | Florida Academic Dermatology CentersOTHER | 1 | May 28, 2010 | clinicaltrials |
| NCT01111396 | Longitudinal Investigation of Hippocampal Function and Morphology in Acute Lymphatic Leukemia (ALL) Patients Treated With Chemotherapy(HIF-ALL) | unknown | — | 10 | Technische Universität DresdenOTHER | 1 | Apr 27, 2010 | clinicaltrials |
| NCT00315419 | Identifying Characteristics of Bone Marrow Failure Syndromes | unknown | — | 450 | Office of Rare Diseases (ORD)NIH | 1 | Apr 21, 2010 | clinicaltrials |
| NCT01104324 | Osteonecrosis in Children With Acute Lymphoblastic Leukemia | unknown | — | 130 | Halton, Jacqueline, M.D.OTHER | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00003073 | Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors | unknown | Phase 1 | 15 | Pacira Pharmaceuticals, IncINDUSTRY | 2 | Mar 23, 2010 | clinicaltrials |
| NCT01089907 | Genomic Changes in Childhood Acute Lymphoblastic Leukemia | unknown | — | 400 | National Taiwan University HospitalOTHER | 1 | Mar 19, 2010 | clinicaltrials |
| NCT00846703 | The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia | unknown | Phase 4 | 600 | Sun Yat-sen UniversityOTHER | 1 | Mar 8, 2010 | clinicaltrials |
| NCT01079507 | Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia | unknown | — | 200 | Samsung Medical CenterOTHER | 1 | Mar 3, 2010 | clinicaltrials |
| NCT01066429 | DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma | unknown | Phase 2 | 30 | Hospital Universitario Principe de AsturiasOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00222612 | Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 | unknown | Phase 4 | 2,100 | University of OxfordOTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00124813 | Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma | unknown | Phase 2 | 80 | University Hospital, BonnOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00740467 | Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders | unknown | Phase 2 | 50 | Institut Paoli-CalmettesOTHER | 1 | Jan 28, 2010 | clinicaltrials |
| NCT00571168 | Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy(EmNa) | unknown | Phase 3 | 362 | Heidelberg UniversityOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT01008735 | Gonadal Toxicity in Women With Hodgkin Lymphoma(FertHD) | unknown | — | 150 | Gruppo Italiano Studio LinfomiOTHER | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00989352 | Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma(PRIMAIN) | unknown | Phase 2 | 56 | University Hospital FreiburgOTHER | 1 | Oct 5, 2009 | clinicaltrials |
| NCT00041730 | Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 90 | FavrilleINDUSTRY | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00192673 | Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses | unknown | Phase 4 | 85 | Nordic Society for Pediatric Hematology and OncologyOTHER | 1 | Sep 30, 2009 | clinicaltrials |
| NCT00980304 | R Retreatment in 1st Relapsed DLBCL | unknown | Phase 2 | — | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Sep 21, 2009 | clinicaltrials |
| NCT00797810 | Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults | unknown | Phase 4 | 25 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00801580 | My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia | unknown | Phase 2 | 3 | University of BolognaOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00598624 | Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)(AlloTreo) | unknown | Phase 2 | 175 | IRCCS San RaffaeleOTHER | 1 | Aug 11, 2009 | clinicaltrials |
| NCT00946374 | Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma(HD-MCL2003) | unknown | Phase 2 | 20 | Heidelberg UniversityOTHER | 1 | Jul 27, 2009 | clinicaltrials |
| NCT00689845 | Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma | unknown | N/A | 120 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00053105 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | unknown | Phase 1 | — | TheradexINDUSTRY | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00069966 | Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 7, 2009 | clinicaltrials |
| NCT00932217 | Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma | unknown | Phase 3 | 180 | University of PisaOTHER | 0 | Jul 3, 2009 | clinicaltrials |
| NCT00927797 | Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)(PERLL) | unknown | Phase 2 | 185 | Heidelberg UniversityOTHER | 0 | Jun 25, 2009 | clinicaltrials |
| NCT00004086 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | unknown | Phase 1 | — | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00910897 | Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) | unknown | Phase 3 | 205 | Intergroupe Francophone du MyelomeNETWORK | 2 | Jun 1, 2009 | clinicaltrials |
| NCT00872352 | Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients | unknown | Phase 3 | 30 | Wolfson Medical CenterOTHER_GOV | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00863187 | Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab | unknown | N/A | 100 | Rambam Health Care CampusOTHER | 0 | Mar 17, 2009 | clinicaltrials |
| NCT00002989 | Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome | unknown | Phase 3 | 207 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Feb 9, 2009 | clinicaltrials |
| NCT00337519 | Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia | unknown | Phase 2 | 82 | Charite University, Berlin, GermanyOTHER | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00821301 | Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma | unknown | Phase 1 | 30 | Immune ControlINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00815568 | Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) | unknown | Phase 2 | 114 | Samsung Medical CenterOTHER | 1 | Dec 30, 2008 | clinicaltrials |
| NCT00810680 | Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL) | unknown | N/A | 10 | All India Institute of Medical SciencesOTHER | 1 | Dec 18, 2008 | clinicaltrials |
| NCT00807196 | Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma | unknown | Phase 1 / Phase 2 | 20 | Maisonneuve-Rosemont HospitalOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00804947 | Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen | unknown | Phase 2 | 50 | Fundacion Para La Investigacion Hospital La FeOTHER | 1 | Dec 9, 2008 | clinicaltrials |
| NCT00800943 | Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy(CRC005) | unknown | Phase 2 | 31 | Chronic Lymphocytic Leukemia Research ConsortiumNETWORK | 1 | Dec 3, 2008 | clinicaltrials |
| NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | unknown | Phase 3 | 240 | Japan Adult Leukemia Study GroupOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00131053 | Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | unknown | Phase 2 | 120 | Japan Adult Leukemia Study GroupOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00779896 | Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study | unknown | Phase 1 / Phase 2 | 15 | McGill UniversityOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00774332 | A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL | unknown | Phase 2 | 37 | Cooperative Study Group A for HematologyNETWORK | 1 | Oct 17, 2008 | clinicaltrials |
| NCT00111865 | Healthy Exercise for Lymphoma Patients (HELP)(HELP) | unknown | Phase 3 | 122 | Lance Armstrong FoundationOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00722930 | Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma(GOTEL-FL1LC) | unknown | Phase 2 | 38 | Grupo Oncológico para el Tratamiento y el Estudio de los LinfomasOTHER | 1 | Jul 28, 2008 | clinicaltrials |
| NCT00039156 | BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Jun 22, 2010source: clinicaltrials